Phase 2CompletedINTERVENTIONAL
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients
ClinicalTrials.gov · NCT00166725 · Registry updated: 2009-11-19
- Condition / research focus
- Prostate Cancer
- Sponsor
- Novartis
- Countries with listed sites
- Italy
- Registry dates and results
- Start: 2004-02. Completion: Not reported (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Octreotide LAR (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Orbassano
Orbassano, Italy
Site recruitment: Not reported